nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ALB—systemic lupus erythematosus	0.0996	1	CbGaD
Imatinib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0337	0.0693	CbGbCtD
Imatinib—PTGS1—Dapsone—systemic lupus erythematosus	0.0221	0.0456	CbGbCtD
Imatinib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0208	0.0428	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0177	0.0365	CbGbCtD
Imatinib—CYP3A7—Dapsone—systemic lupus erythematosus	0.0177	0.0365	CbGbCtD
Imatinib—ABCA3—alveolus of lung—systemic lupus erythematosus	0.0172	0.183	CbGeAlD
Imatinib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0167	0.0344	CbGbCtD
Imatinib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0158	0.0325	CbGbCtD
Imatinib—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0143	0.0295	CbGbCtD
Imatinib—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0139	0.0286	CbGbCtD
Imatinib—CYP3A5—Dapsone—systemic lupus erythematosus	0.0133	0.0274	CbGbCtD
Imatinib—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0125	0.0258	CbGbCtD
Imatinib—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0123	0.0254	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0123	0.0254	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0116	0.024	CbGbCtD
Imatinib—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0116	0.024	CbGbCtD
Imatinib—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0115	0.0237	CbGbCtD
Imatinib—ALB—Prednisone—systemic lupus erythematosus	0.0115	0.0236	CbGbCtD
Imatinib—CYP2C19—Dapsone—systemic lupus erythematosus	0.0107	0.0221	CbGbCtD
Imatinib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0104	0.0214	CbGbCtD
Imatinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00989	0.0204	CbGbCtD
Imatinib—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00925	0.019	CbGbCtD
Imatinib—CYP2C9—Dapsone—systemic lupus erythematosus	0.00891	0.0184	CbGbCtD
Imatinib—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00873	0.018	CbGbCtD
Imatinib—ABCG2—Methotrexate—systemic lupus erythematosus	0.00834	0.0172	CbGbCtD
Imatinib—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.00767	0.0158	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.00767	0.0158	CbGbCtD
Imatinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0075	0.0154	CbGbCtD
Imatinib—CYP2C19—Prednisone—systemic lupus erythematosus	0.00743	0.0153	CbGbCtD
Imatinib—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00704	0.0145	CbGbCtD
Imatinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00643	0.0132	CbGbCtD
Imatinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.00635	0.0131	CbGbCtD
Imatinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00602	0.0124	CbGbCtD
Imatinib—ABCB1—Prednisone—systemic lupus erythematosus	0.00599	0.0123	CbGbCtD
Imatinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00593	0.0122	CbGbCtD
Imatinib—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00586	0.0121	CbGbCtD
Imatinib—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00575	0.0118	CbGbCtD
Imatinib—ALB—Methotrexate—systemic lupus erythematosus	0.00575	0.0118	CbGbCtD
Imatinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00568	0.0117	CbGbCtD
Imatinib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00535	0.011	CbGbCtD
Imatinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00518	0.0107	CbGbCtD
Imatinib—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00464	0.00955	CbGbCtD
Imatinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00449	0.00925	CbGbCtD
Imatinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00449	0.00925	CbGbCtD
Imatinib—CYP2C9—cardial valve—systemic lupus erythematosus	0.00426	0.0453	CbGeAlD
Imatinib—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00386	0.00794	CbGbCtD
Imatinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00385	0.00794	CbGbCtD
Imatinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0038	0.00783	CbGbCtD
Imatinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00374	0.00771	CbGbCtD
Imatinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00361	0.00742	CbGbCtD
Imatinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00359	0.0074	CbGbCtD
Imatinib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00353	0.00726	CbGbCtD
Imatinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00341	0.00701	CbGbCtD
Imatinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00301	0.00619	CbGbCtD
Imatinib—Ponatinib—LYN—systemic lupus erythematosus	0.00281	0.463	CrCbGaD
Imatinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00224	0.00462	CbGbCtD
Imatinib—Nilotinib—LYN—systemic lupus erythematosus	0.00208	0.341	CrCbGaD
Imatinib—DDR1—nephron tubule—systemic lupus erythematosus	0.00136	0.0145	CbGeAlD
Imatinib—ABCA3—cortex of kidney—systemic lupus erythematosus	0.00126	0.0135	CbGeAlD
Imatinib—Nilotinib—BLK—systemic lupus erythematosus	0.00119	0.196	CrCbGaD
Imatinib—CYP2C19—urine—systemic lupus erythematosus	0.00119	0.0126	CbGeAlD
Imatinib—DDR1—cortex of kidney—systemic lupus erythematosus	0.00117	0.0124	CbGeAlD
Imatinib—KIT—endothelium—systemic lupus erythematosus	0.00108	0.0115	CbGeAlD
Imatinib—CSF1R—blood plasma—systemic lupus erythematosus	0.00105	0.0112	CbGeAlD
Imatinib—ABCA3—tendon—systemic lupus erythematosus	0.00105	0.0112	CbGeAlD
Imatinib—CYP1A2—urine—systemic lupus erythematosus	0.000968	0.0103	CbGeAlD
Imatinib—DDR1—tendon—systemic lupus erythematosus	0.000968	0.0103	CbGeAlD
Imatinib—KIT—blood plasma—systemic lupus erythematosus	0.000956	0.0102	CbGeAlD
Imatinib—ABCA3—lung—systemic lupus erythematosus	0.00092	0.00979	CbGeAlD
Imatinib—CYP2C9—urine—systemic lupus erythematosus	0.000919	0.00977	CbGeAlD
Imatinib—CA1—blood plasma—systemic lupus erythematosus	0.000874	0.0093	CbGeAlD
Imatinib—ABCA3—nervous system—systemic lupus erythematosus	0.000852	0.00907	CbGeAlD
Imatinib—DDR1—lung—systemic lupus erythematosus	0.000849	0.00903	CbGeAlD
Imatinib—PIP4K2C—nephron tubule—systemic lupus erythematosus	0.000842	0.00896	CbGeAlD
Imatinib—CA3—connective tissue—systemic lupus erythematosus	0.00083	0.00883	CbGeAlD
Imatinib—ABCA3—central nervous system—systemic lupus erythematosus	0.000821	0.00873	CbGeAlD
Imatinib—CA7—kidney—systemic lupus erythematosus	0.00077	0.00819	CbGeAlD
Imatinib—PIP4K2C—cortex of kidney—systemic lupus erythematosus	0.000721	0.00766	CbGeAlD
Imatinib—CYP3A4—urine—systemic lupus erythematosus	0.000701	0.00745	CbGeAlD
Imatinib—CYP2D6—urine—systemic lupus erythematosus	0.000689	0.00733	CbGeAlD
Imatinib—PDGFRA—connective tissue—systemic lupus erythematosus	0.000637	0.00677	CbGeAlD
Imatinib—ABL2—tendon—systemic lupus erythematosus	0.000631	0.00672	CbGeAlD
Imatinib—CYP2C19—blood plasma—systemic lupus erythematosus	0.000618	0.00658	CbGeAlD
Imatinib—NQO2—nephron tubule—systemic lupus erythematosus	0.000618	0.00658	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.000607	0.00646	CbGeAlD
Imatinib—PIP4K2C—tendon—systemic lupus erythematosus	0.000597	0.00635	CbGeAlD
Imatinib—CA12—connective tissue—systemic lupus erythematosus	0.000588	0.00625	CbGeAlD
Imatinib—SLC22A2—nephron tubule—systemic lupus erythematosus	0.000586	0.00623	CbGeAlD
Imatinib—PIP4K2C—bone marrow—systemic lupus erythematosus	0.000579	0.00616	CbGeAlD
Imatinib—CA3—tendon—systemic lupus erythematosus	0.00057	0.00607	CbGeAlD
Imatinib—CA2—blood plasma—systemic lupus erythematosus	0.000567	0.00603	CbGeAlD
Imatinib—CSF1R—connective tissue—systemic lupus erythematosus	0.000561	0.00596	CbGeAlD
Imatinib—ABL2—lung—systemic lupus erythematosus	0.000554	0.00589	CbGeAlD
Imatinib—CA3—bone marrow—systemic lupus erythematosus	0.000553	0.00588	CbGeAlD
Imatinib—CA9—tendon—systemic lupus erythematosus	0.000546	0.00581	CbGeAlD
Imatinib—NQO2—kidney—systemic lupus erythematosus	0.000543	0.00578	CbGeAlD
Imatinib—NQO2—cortex of kidney—systemic lupus erythematosus	0.000529	0.00563	CbGeAlD
Imatinib—PIP4K2C—lung—systemic lupus erythematosus	0.000524	0.00558	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00052	0.00553	CbGeAlD
Imatinib—CA14—tendon—systemic lupus erythematosus	0.000518	0.00551	CbGeAlD
Imatinib—SLC22A2—kidney—systemic lupus erythematosus	0.000515	0.00548	CbGeAlD
Imatinib—LCK—bone marrow—systemic lupus erythematosus	0.000514	0.00546	CbGeAlD
Imatinib—KIT—connective tissue—systemic lupus erythematosus	0.000509	0.00541	CbGeAlD
Imatinib—CSF1R—skin of body—systemic lupus erythematosus	0.000506	0.00538	CbGeAlD
Imatinib—CYP1A2—blood plasma—systemic lupus erythematosus	0.000505	0.00537	CbGeAlD
Imatinib—SLC22A2—cortex of kidney—systemic lupus erythematosus	0.000501	0.00533	CbGeAlD
Imatinib—CA3—lung—systemic lupus erythematosus	0.000501	0.00532	CbGeAlD
Imatinib—CA12—kidney—systemic lupus erythematosus	0.0005	0.00532	CbGeAlD
Imatinib—PDGFRB—connective tissue—systemic lupus erythematosus	0.000497	0.00529	CbGeAlD
Imatinib—SLC47A1—nephron tubule—systemic lupus erythematosus	0.000496	0.00528	CbGeAlD
Imatinib—KIT—nephron tubule—systemic lupus erythematosus	0.000493	0.00524	CbGeAlD
Imatinib—PTGS1—endothelium—systemic lupus erythematosus	0.000493	0.00524	CbGeAlD
Imatinib—CYP3A5—blood plasma—systemic lupus erythematosus	0.000487	0.00518	CbGeAlD
Imatinib—PIP4K2C—nervous system—systemic lupus erythematosus	0.000485	0.00516	CbGeAlD
Imatinib—CYP2C9—blood plasma—systemic lupus erythematosus	0.000479	0.0051	CbGeAlD
Imatinib—PIP4K2C—central nervous system—systemic lupus erythematosus	0.000467	0.00497	CbGeAlD
Imatinib—PDGFRA—lymphoid tissue—systemic lupus erythematosus	0.000466	0.00495	CbGeAlD
Imatinib—LCK—lung—systemic lupus erythematosus	0.000465	0.00495	CbGeAlD
Imatinib—CA3—nervous system—systemic lupus erythematosus	0.000464	0.00493	CbGeAlD
Imatinib—KIT—skin of body—systemic lupus erythematosus	0.00046	0.00489	CbGeAlD
Imatinib—PDGFRB—skin of body—systemic lupus erythematosus	0.000449	0.00478	CbGeAlD
Imatinib—CA3—central nervous system—systemic lupus erythematosus	0.000446	0.00475	CbGeAlD
Imatinib—ABL1—connective tissue—systemic lupus erythematosus	0.000443	0.00471	CbGeAlD
Imatinib—NQO2—tendon—systemic lupus erythematosus	0.000439	0.00467	CbGeAlD
Imatinib—PTGS1—blood plasma—systemic lupus erythematosus	0.000438	0.00466	CbGeAlD
Imatinib—PDGFRA—tendon—systemic lupus erythematosus	0.000438	0.00466	CbGeAlD
Imatinib—SLC47A1—kidney—systemic lupus erythematosus	0.000436	0.00464	CbGeAlD
Imatinib—KIT—kidney—systemic lupus erythematosus	0.000433	0.00461	CbGeAlD
Imatinib—ABL1—nephron tubule—systemic lupus erythematosus	0.000429	0.00457	CbGeAlD
Imatinib—NQO2—bone marrow—systemic lupus erythematosus	0.000425	0.00452	CbGeAlD
Imatinib—SLC47A1—cortex of kidney—systemic lupus erythematosus	0.000424	0.00451	CbGeAlD
Imatinib—PDGFRB—kidney—systemic lupus erythematosus	0.000423	0.0045	CbGeAlD
Imatinib—KIT—cortex of kidney—systemic lupus erythematosus	0.000422	0.00449	CbGeAlD
Imatinib—PDGFRB—cortex of kidney—systemic lupus erythematosus	0.000412	0.00438	CbGeAlD
Imatinib—CSF1R—lymphoid tissue—systemic lupus erythematosus	0.00041	0.00436	CbGeAlD
Imatinib—ABL1—skin of body—systemic lupus erythematosus	0.0004	0.00426	CbGeAlD
Imatinib—CA1—kidney—systemic lupus erythematosus	0.000396	0.00422	CbGeAlD
Imatinib—CSF1R—tendon—systemic lupus erythematosus	0.000385	0.0041	CbGeAlD
Imatinib—NQO2—lung—systemic lupus erythematosus	0.000385	0.0041	CbGeAlD
Imatinib—PDGFRA—lung—systemic lupus erythematosus	0.000384	0.00409	CbGeAlD
Imatinib—ABL1—kidney—systemic lupus erythematosus	0.000377	0.00401	CbGeAlD
Imatinib—CSF1R—bone marrow—systemic lupus erythematosus	0.000373	0.00397	CbGeAlD
Imatinib—KIT—lymphoid tissue—systemic lupus erythematosus	0.000372	0.00396	CbGeAlD
Imatinib—ABL1—cortex of kidney—systemic lupus erythematosus	0.000367	0.00391	CbGeAlD
Imatinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000366	0.00389	CbGeAlD
Imatinib—SLC22A1—kidney—systemic lupus erythematosus	0.000364	0.00387	CbGeAlD
Imatinib—PDGFRB—lymphoid tissue—systemic lupus erythematosus	0.000364	0.00387	CbGeAlD
Imatinib—CYP2D6—blood plasma—systemic lupus erythematosus	0.00036	0.00383	CbGeAlD
Imatinib—NQO2—nervous system—systemic lupus erythematosus	0.000357	0.00379	CbGeAlD
Imatinib—PDGFRA—nervous system—systemic lupus erythematosus	0.000356	0.00378	CbGeAlD
Imatinib—CA12—lung—systemic lupus erythematosus	0.000354	0.00377	CbGeAlD
Imatinib—SLC47A1—tendon—systemic lupus erythematosus	0.000352	0.00374	CbGeAlD
Imatinib—NQO2—central nervous system—systemic lupus erythematosus	0.000343	0.00365	CbGeAlD
Imatinib—PDGFRA—central nervous system—systemic lupus erythematosus	0.000342	0.00364	CbGeAlD
Imatinib—PDGFRB—tendon—systemic lupus erythematosus	0.000342	0.00363	CbGeAlD
Imatinib—CA1—lymphoid tissue—systemic lupus erythematosus	0.00034	0.00362	CbGeAlD
Imatinib—KIT—bone marrow—systemic lupus erythematosus	0.000339	0.0036	CbGeAlD
Imatinib—CSF1R—lung—systemic lupus erythematosus	0.000338	0.0036	CbGeAlD
Imatinib—PDGFRB—bone marrow—systemic lupus erythematosus	0.000331	0.00352	CbGeAlD
Imatinib—CA12—nervous system—systemic lupus erythematosus	0.000328	0.00349	CbGeAlD
Imatinib—ABL1—lymphoid tissue—systemic lupus erythematosus	0.000324	0.00345	CbGeAlD
Imatinib—CA12—central nervous system—systemic lupus erythematosus	0.000316	0.00336	CbGeAlD
Imatinib—CSF1R—nervous system—systemic lupus erythematosus	0.000313	0.00333	CbGeAlD
Imatinib—ORM1—bone marrow—systemic lupus erythematosus	0.00031	0.0033	CbGeAlD
Imatinib—CA1—bone marrow—systemic lupus erythematosus	0.00031	0.0033	CbGeAlD
Imatinib—SLC47A1—lung—systemic lupus erythematosus	0.000309	0.00328	CbGeAlD
Imatinib—KIT—lung—systemic lupus erythematosus	0.000307	0.00327	CbGeAlD
Imatinib—ABL1—tendon—systemic lupus erythematosus	0.000305	0.00324	CbGeAlD
Imatinib—CA2—connective tissue—systemic lupus erythematosus	0.000302	0.00321	CbGeAlD
Imatinib—CSF1R—central nervous system—systemic lupus erythematosus	0.000301	0.00321	CbGeAlD
Imatinib—PDGFRB—lung—systemic lupus erythematosus	0.0003	0.00319	CbGeAlD
Imatinib—ABL1—bone marrow—systemic lupus erythematosus	0.000295	0.00314	CbGeAlD
Imatinib—CA2—nephron tubule—systemic lupus erythematosus	0.000292	0.00311	CbGeAlD
Imatinib—SLC47A1—nervous system—systemic lupus erythematosus	0.000286	0.00304	CbGeAlD
Imatinib—KIT—nervous system—systemic lupus erythematosus	0.000284	0.00302	CbGeAlD
Imatinib—ORM1—lung—systemic lupus erythematosus	0.000281	0.00299	CbGeAlD
Imatinib—CA1—lung—systemic lupus erythematosus	0.000281	0.00299	CbGeAlD
Imatinib—PDGFRB—nervous system—systemic lupus erythematosus	0.000278	0.00295	CbGeAlD
Imatinib—SLC47A1—central nervous system—systemic lupus erythematosus	0.000275	0.00293	CbGeAlD
Imatinib—KIT—central nervous system—systemic lupus erythematosus	0.000274	0.00291	CbGeAlD
Imatinib—CA2—skin of body—systemic lupus erythematosus	0.000272	0.0029	CbGeAlD
Imatinib—ABCG2—nephron tubule—systemic lupus erythematosus	0.000271	0.00288	CbGeAlD
Imatinib—PDGFRB—central nervous system—systemic lupus erythematosus	0.000267	0.00284	CbGeAlD
Imatinib—ABL1—lung—systemic lupus erythematosus	0.000267	0.00284	CbGeAlD
Imatinib—ORM1—nervous system—systemic lupus erythematosus	0.00026	0.00277	CbGeAlD
Imatinib—CA1—nervous system—systemic lupus erythematosus	0.00026	0.00277	CbGeAlD
Imatinib—ABCB1—blood plasma—systemic lupus erythematosus	0.000259	0.00275	CbGeAlD
Imatinib—CA2—kidney—systemic lupus erythematosus	0.000257	0.00273	CbGeAlD
Imatinib—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000251	0.00267	CbGeAlD
Imatinib—ORM1—central nervous system—systemic lupus erythematosus	0.000251	0.00267	CbGeAlD
Imatinib—CA1—central nervous system—systemic lupus erythematosus	0.00025	0.00266	CbGeAlD
Imatinib—CA2—cortex of kidney—systemic lupus erythematosus	0.00025	0.00266	CbGeAlD
Imatinib—ABL1—nervous system—systemic lupus erythematosus	0.000248	0.00263	CbGeAlD
Imatinib—SLC22A1—nervous system—systemic lupus erythematosus	0.000239	0.00254	CbGeAlD
Imatinib—ABL1—central nervous system—systemic lupus erythematosus	0.000238	0.00253	CbGeAlD
Imatinib—PTGS1—connective tissue—systemic lupus erythematosus	0.000233	0.00248	CbGeAlD
Imatinib—SLC22A1—central nervous system—systemic lupus erythematosus	0.00023	0.00244	CbGeAlD
Imatinib—CYP3A5—kidney—systemic lupus erythematosus	0.000221	0.00235	CbGeAlD
Imatinib—CA2—lymphoid tissue—systemic lupus erythematosus	0.000221	0.00235	CbGeAlD
Imatinib—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000215	0.00229	CbGeAlD
Imatinib—PTGS1—skin of body—systemic lupus erythematosus	0.00021	0.00224	CbGeAlD
Imatinib—CA2—tendon—systemic lupus erythematosus	0.000207	0.00221	CbGeAlD
Imatinib—CA2—bone marrow—systemic lupus erythematosus	0.000201	0.00214	CbGeAlD
Imatinib—PTGS1—kidney—systemic lupus erythematosus	0.000198	0.00211	CbGeAlD
Imatinib—ABCG2—bone marrow—systemic lupus erythematosus	0.000186	0.00198	CbGeAlD
Imatinib—CA2—lung—systemic lupus erythematosus	0.000182	0.00194	CbGeAlD
Imatinib—ABCG2—lung—systemic lupus erythematosus	0.000169	0.00179	CbGeAlD
Imatinib—CA2—nervous system—systemic lupus erythematosus	0.000169	0.00179	CbGeAlD
Imatinib—CYP3A4—kidney—systemic lupus erythematosus	0.000166	0.00176	CbGeAlD
Imatinib—CYP2D6—kidney—systemic lupus erythematosus	0.000163	0.00173	CbGeAlD
Imatinib—CA2—central nervous system—systemic lupus erythematosus	0.000162	0.00173	CbGeAlD
Imatinib—CYP1A2—lung—systemic lupus erythematosus	0.000162	0.00173	CbGeAlD
Imatinib—PTGS1—tendon—systemic lupus erythematosus	0.00016	0.0017	CbGeAlD
Imatinib—CYP3A5—lung—systemic lupus erythematosus	0.000156	0.00166	CbGeAlD
Imatinib—PTGS1—lung—systemic lupus erythematosus	0.000141	0.0015	CbGeAlD
Imatinib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000133	0.00142	CbGeAlD
Imatinib—PTGS1—nervous system—systemic lupus erythematosus	0.00013	0.00138	CbGeAlD
Imatinib—PTGS1—central nervous system—systemic lupus erythematosus	0.000125	0.00133	CbGeAlD
Imatinib—ABCB1—kidney—systemic lupus erythematosus	0.000117	0.00125	CbGeAlD
Imatinib—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000114	0.00122	CbGeAlD
Imatinib—CYP3A4—nervous system—systemic lupus erythematosus	0.000109	0.00116	CbGeAlD
Imatinib—CYP2D6—nervous system—systemic lupus erythematosus	0.000107	0.00114	CbGeAlD
Imatinib—CYP3A4—central nervous system—systemic lupus erythematosus	0.000105	0.00111	CbGeAlD
Imatinib—CYP2D6—central nervous system—systemic lupus erythematosus	0.000103	0.0011	CbGeAlD
Imatinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000101	0.00107	CbGeAlD
Imatinib—ABCB1—bone marrow—systemic lupus erythematosus	9.17e-05	0.000976	CbGeAlD
Imatinib—ABCB1—lung—systemic lupus erythematosus	8.31e-05	0.000884	CbGeAlD
Imatinib—ABCB1—nervous system—systemic lupus erythematosus	7.7e-05	0.000819	CbGeAlD
Imatinib—ABCB1—central nervous system—systemic lupus erythematosus	7.41e-05	0.000788	CbGeAlD
Imatinib—Pain—Hydrocortisone—systemic lupus erythematosus	5.25e-05	0.000267	CcSEcCtD
Imatinib—Oedema—Dexamethasone—systemic lupus erythematosus	5.24e-05	0.000267	CcSEcCtD
Imatinib—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	5.24e-05	0.000267	CcSEcCtD
Imatinib—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	5.24e-05	0.000267	CcSEcCtD
Imatinib—Oedema—Betamethasone—systemic lupus erythematosus	5.24e-05	0.000267	CcSEcCtD
Imatinib—Insomnia—Triamcinolone—systemic lupus erythematosus	5.22e-05	0.000266	CcSEcCtD
Imatinib—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.21e-05	0.000265	CcSEcCtD
Imatinib—Infection—Betamethasone—systemic lupus erythematosus	5.21e-05	0.000265	CcSEcCtD
Imatinib—Infection—Dexamethasone—systemic lupus erythematosus	5.21e-05	0.000265	CcSEcCtD
Imatinib—Ill-defined disorder—Prednisone—systemic lupus erythematosus	5.19e-05	0.000264	CcSEcCtD
Imatinib—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.19e-05	0.000264	CcSEcCtD
Imatinib—Feeling abnormal—Prednisolone—systemic lupus erythematosus	5.18e-05	0.000264	CcSEcCtD
Imatinib—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.18e-05	0.000264	CcSEcCtD
Imatinib—Anaemia—Prednisone—systemic lupus erythematosus	5.17e-05	0.000263	CcSEcCtD
Imatinib—Shock—Dexamethasone—systemic lupus erythematosus	5.16e-05	0.000263	CcSEcCtD
Imatinib—Shock—Betamethasone—systemic lupus erythematosus	5.16e-05	0.000263	CcSEcCtD
Imatinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.15e-05	0.000262	CcSEcCtD
Imatinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	5.14e-05	0.000262	CcSEcCtD
Imatinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	5.14e-05	0.000262	CcSEcCtD
Imatinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.13e-05	0.000261	CcSEcCtD
Imatinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.13e-05	0.000261	CcSEcCtD
Imatinib—Tachycardia—Betamethasone—systemic lupus erythematosus	5.12e-05	0.000261	CcSEcCtD
Imatinib—Tachycardia—Dexamethasone—systemic lupus erythematosus	5.12e-05	0.000261	CcSEcCtD
Imatinib—Angioedema—Prednisone—systemic lupus erythematosus	5.11e-05	0.00026	CcSEcCtD
Imatinib—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	5.09e-05	0.000259	CcSEcCtD
Imatinib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.09e-05	0.000259	CcSEcCtD
Imatinib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000259	CcSEcCtD
Imatinib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.07e-05	0.000258	CcSEcCtD
Imatinib—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	5.07e-05	0.000258	CcSEcCtD
Imatinib—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	5.07e-05	0.000258	CcSEcCtD
Imatinib—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	5.06e-05	0.000257	CcSEcCtD
Imatinib—Malaise—Prednisone—systemic lupus erythematosus	5.04e-05	0.000257	CcSEcCtD
Imatinib—Vertigo—Prednisone—systemic lupus erythematosus	5.03e-05	0.000256	CcSEcCtD
Imatinib—Eye disorder—Methotrexate—systemic lupus erythematosus	5.02e-05	0.000256	CcSEcCtD
Imatinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.02e-05	0.000255	CcSEcCtD
Imatinib—Syncope—Prednisone—systemic lupus erythematosus	5.02e-05	0.000255	CcSEcCtD
Imatinib—Tinnitus—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000255	CcSEcCtD
Imatinib—Anorexia—Dexamethasone—systemic lupus erythematosus	5e-05	0.000254	CcSEcCtD
Imatinib—Anorexia—Betamethasone—systemic lupus erythematosus	5e-05	0.000254	CcSEcCtD
Imatinib—Urticaria—Prednisolone—systemic lupus erythematosus	4.99e-05	0.000254	CcSEcCtD
Imatinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.98e-05	0.000254	CcSEcCtD
Imatinib—Fatigue—Triamcinolone—systemic lupus erythematosus	4.98e-05	0.000254	CcSEcCtD
Imatinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.97e-05	0.000253	CcSEcCtD
Imatinib—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.96e-05	0.000253	CcSEcCtD
Imatinib—Asthenia—Cyclosporine—systemic lupus erythematosus	4.95e-05	0.000252	CcSEcCtD
Imatinib—Pain—Triamcinolone—systemic lupus erythematosus	4.94e-05	0.000252	CcSEcCtD
Imatinib—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.92e-05	0.00025	CcSEcCtD
Imatinib—Hypotension—Dexamethasone—systemic lupus erythematosus	4.9e-05	0.000249	CcSEcCtD
Imatinib—Hypotension—Betamethasone—systemic lupus erythematosus	4.9e-05	0.000249	CcSEcCtD
Imatinib—Pruritus—Cyclosporine—systemic lupus erythematosus	4.88e-05	0.000249	CcSEcCtD
Imatinib—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.87e-05	0.000248	CcSEcCtD
Imatinib—Angiopathy—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000248	CcSEcCtD
Imatinib—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.85e-05	0.000247	CcSEcCtD
Imatinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.85e-05	0.000247	CcSEcCtD
Imatinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.85e-05	0.000247	CcSEcCtD
Imatinib—Convulsion—Prednisone—systemic lupus erythematosus	4.85e-05	0.000247	CcSEcCtD
Imatinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.84e-05	0.000246	CcSEcCtD
Imatinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.83e-05	0.000246	CcSEcCtD
Imatinib—Hypertension—Prednisone—systemic lupus erythematosus	4.83e-05	0.000246	CcSEcCtD
Imatinib—Chills—Methotrexate—systemic lupus erythematosus	4.82e-05	0.000245	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.78e-05	0.000243	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.78e-05	0.000243	CcSEcCtD
Imatinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.76e-05	0.000243	CcSEcCtD
Imatinib—Myalgia—Prednisone—systemic lupus erythematosus	4.76e-05	0.000243	CcSEcCtD
Imatinib—Arthralgia—Prednisone—systemic lupus erythematosus	4.76e-05	0.000243	CcSEcCtD
Imatinib—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.76e-05	0.000242	CcSEcCtD
Imatinib—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.75e-05	0.000242	CcSEcCtD
Imatinib—Anxiety—Prednisone—systemic lupus erythematosus	4.75e-05	0.000242	CcSEcCtD
Imatinib—Alopecia—Methotrexate—systemic lupus erythematosus	4.75e-05	0.000242	CcSEcCtD
Imatinib—Insomnia—Betamethasone—systemic lupus erythematosus	4.74e-05	0.000241	CcSEcCtD
Imatinib—Insomnia—Dexamethasone—systemic lupus erythematosus	4.74e-05	0.000241	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.73e-05	0.000241	CcSEcCtD
Imatinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.72e-05	0.000241	CcSEcCtD
Imatinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.71e-05	0.00024	CcSEcCtD
Imatinib—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.71e-05	0.00024	CcSEcCtD
Imatinib—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.71e-05	0.00024	CcSEcCtD
Imatinib—Discomfort—Prednisone—systemic lupus erythematosus	4.7e-05	0.00024	CcSEcCtD
Imatinib—Mental disorder—Methotrexate—systemic lupus erythematosus	4.7e-05	0.00024	CcSEcCtD
Imatinib—Erythema—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000238	CcSEcCtD
Imatinib—Malnutrition—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000238	CcSEcCtD
Imatinib—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.63e-05	0.000236	CcSEcCtD
Imatinib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.61e-05	0.000235	CcSEcCtD
Imatinib—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.61e-05	0.000235	CcSEcCtD
Imatinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.61e-05	0.000235	CcSEcCtD
Imatinib—Urticaria—Triamcinolone—systemic lupus erythematosus	4.59e-05	0.000234	CcSEcCtD
Imatinib—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.58e-05	0.000233	CcSEcCtD
Imatinib—Dysgeusia—Methotrexate—systemic lupus erythematosus	4.58e-05	0.000233	CcSEcCtD
Imatinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.57e-05	0.000233	CcSEcCtD
Imatinib—Dizziness—Cyclosporine—systemic lupus erythematosus	4.57e-05	0.000232	CcSEcCtD
Imatinib—Oedema—Prednisone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Imatinib—Anaphylactic shock—Prednisone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Imatinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Imatinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Imatinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Imatinib—Infection—Prednisone—systemic lupus erythematosus	4.53e-05	0.000231	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.53e-05	0.00023	CcSEcCtD
Imatinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.53e-05	0.00023	CcSEcCtD
Imatinib—Back pain—Methotrexate—systemic lupus erythematosus	4.52e-05	0.00023	CcSEcCtD
Imatinib—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.52e-05	0.00023	CcSEcCtD
Imatinib—Fatigue—Betamethasone—systemic lupus erythematosus	4.52e-05	0.00023	CcSEcCtD
Imatinib—Fatigue—Dexamethasone—systemic lupus erythematosus	4.52e-05	0.00023	CcSEcCtD
Imatinib—Shock—Prednisone—systemic lupus erythematosus	4.49e-05	0.000229	CcSEcCtD
Imatinib—Pain—Betamethasone—systemic lupus erythematosus	4.48e-05	0.000228	CcSEcCtD
Imatinib—Pain—Dexamethasone—systemic lupus erythematosus	4.48e-05	0.000228	CcSEcCtD
Imatinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.48e-05	0.000228	CcSEcCtD
Imatinib—Tachycardia—Prednisone—systemic lupus erythematosus	4.46e-05	0.000227	CcSEcCtD
Imatinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.45e-05	0.000227	CcSEcCtD
Imatinib—Skin disorder—Prednisone—systemic lupus erythematosus	4.43e-05	0.000226	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.41e-05	0.000225	CcSEcCtD
Imatinib—Vision blurred—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000224	CcSEcCtD
Imatinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000224	CcSEcCtD
Imatinib—Vomiting—Cyclosporine—systemic lupus erythematosus	4.39e-05	0.000224	CcSEcCtD
Imatinib—Rash—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000222	CcSEcCtD
Imatinib—Anorexia—Prednisone—systemic lupus erythematosus	4.35e-05	0.000222	CcSEcCtD
Imatinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000221	CcSEcCtD
Imatinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.34e-05	0.000221	CcSEcCtD
Imatinib—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000221	CcSEcCtD
Imatinib—Headache—Cyclosporine—systemic lupus erythematosus	4.32e-05	0.00022	CcSEcCtD
Imatinib—Anaemia—Methotrexate—systemic lupus erythematosus	4.32e-05	0.00022	CcSEcCtD
Imatinib—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.32e-05	0.00022	CcSEcCtD
Imatinib—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.32e-05	0.00022	CcSEcCtD
Imatinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.29e-05	0.000218	CcSEcCtD
Imatinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.29e-05	0.000218	CcSEcCtD
Imatinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.28e-05	0.000218	CcSEcCtD
Imatinib—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.26e-05	0.000217	CcSEcCtD
Imatinib—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.25e-05	0.000216	CcSEcCtD
Imatinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.25e-05	0.000216	CcSEcCtD
Imatinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.24e-05	0.000216	CcSEcCtD
Imatinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.22e-05	0.000215	CcSEcCtD
Imatinib—Malaise—Methotrexate—systemic lupus erythematosus	4.22e-05	0.000215	CcSEcCtD
Imatinib—Vertigo—Methotrexate—systemic lupus erythematosus	4.2e-05	0.000214	CcSEcCtD
Imatinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.2e-05	0.000214	CcSEcCtD
Imatinib—Leukopenia—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000213	CcSEcCtD
Imatinib—Urticaria—Dexamethasone—systemic lupus erythematosus	4.16e-05	0.000212	CcSEcCtD
Imatinib—Urticaria—Betamethasone—systemic lupus erythematosus	4.16e-05	0.000212	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.16e-05	0.000212	CcSEcCtD
Imatinib—Dizziness—Prednisolone—systemic lupus erythematosus	4.15e-05	0.000212	CcSEcCtD
Imatinib—Asthenia—Triamcinolone—systemic lupus erythematosus	4.14e-05	0.000211	CcSEcCtD
Imatinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.000211	CcSEcCtD
Imatinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.14e-05	0.000211	CcSEcCtD
Imatinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.000211	CcSEcCtD
Imatinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.14e-05	0.000211	CcSEcCtD
Imatinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.14e-05	0.000211	CcSEcCtD
Imatinib—Insomnia—Prednisone—systemic lupus erythematosus	4.13e-05	0.00021	CcSEcCtD
Imatinib—Nausea—Cyclosporine—systemic lupus erythematosus	4.1e-05	0.000209	CcSEcCtD
Imatinib—Paraesthesia—Prednisone—systemic lupus erythematosus	4.1e-05	0.000209	CcSEcCtD
Imatinib—Pruritus—Triamcinolone—systemic lupus erythematosus	4.09e-05	0.000208	CcSEcCtD
Imatinib—Cough—Methotrexate—systemic lupus erythematosus	4.08e-05	0.000208	CcSEcCtD
Imatinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.08e-05	0.000208	CcSEcCtD
Imatinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.06e-05	0.000207	CcSEcCtD
Imatinib—Convulsion—Methotrexate—systemic lupus erythematosus	4.05e-05	0.000206	CcSEcCtD
Imatinib—Dyspepsia—Prednisone—systemic lupus erythematosus	4.02e-05	0.000205	CcSEcCtD
Imatinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4e-05	0.000204	CcSEcCtD
Imatinib—Arthralgia—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000203	CcSEcCtD
Imatinib—Myalgia—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000203	CcSEcCtD
Imatinib—Chest pain—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000203	CcSEcCtD
Imatinib—Decreased appetite—Prednisone—systemic lupus erythematosus	3.97e-05	0.000202	CcSEcCtD
Imatinib—Rash—Prednisolone—systemic lupus erythematosus	3.96e-05	0.000202	CcSEcCtD
Imatinib—Dermatitis—Prednisolone—systemic lupus erythematosus	3.96e-05	0.000202	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000201	CcSEcCtD
Imatinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.94e-05	0.000201	CcSEcCtD
Imatinib—Fatigue—Prednisone—systemic lupus erythematosus	3.94e-05	0.0002	CcSEcCtD
Imatinib—Headache—Prednisolone—systemic lupus erythematosus	3.94e-05	0.0002	CcSEcCtD
Imatinib—Discomfort—Methotrexate—systemic lupus erythematosus	3.93e-05	0.0002	CcSEcCtD
Imatinib—Constipation—Prednisone—systemic lupus erythematosus	3.9e-05	0.000199	CcSEcCtD
Imatinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.9e-05	0.000199	CcSEcCtD
Imatinib—Rash—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.000197	CcSEcCtD
Imatinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.000197	CcSEcCtD
Imatinib—Confusional state—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000196	CcSEcCtD
Imatinib—Headache—Hydrocortisone—systemic lupus erythematosus	3.84e-05	0.000196	CcSEcCtD
Imatinib—Dizziness—Triamcinolone—systemic lupus erythematosus	3.82e-05	0.000195	CcSEcCtD
Imatinib—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.81e-05	0.000194	CcSEcCtD
Imatinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.81e-05	0.000194	CcSEcCtD
Imatinib—Infection—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000193	CcSEcCtD
Imatinib—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.76e-05	0.000192	CcSEcCtD
Imatinib—Asthenia—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000192	CcSEcCtD
Imatinib—Asthenia—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000192	CcSEcCtD
Imatinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000191	CcSEcCtD
Imatinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.74e-05	0.00019	CcSEcCtD
Imatinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.73e-05	0.00019	CcSEcCtD
Imatinib—Nausea—Prednisolone—systemic lupus erythematosus	3.73e-05	0.00019	CcSEcCtD
Imatinib—Pruritus—Betamethasone—systemic lupus erythematosus	3.71e-05	0.000189	CcSEcCtD
Imatinib—Pruritus—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.000189	CcSEcCtD
Imatinib—Skin disorder—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000189	CcSEcCtD
Imatinib—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000188	CcSEcCtD
Imatinib—Vomiting—Triamcinolone—systemic lupus erythematosus	3.67e-05	0.000187	CcSEcCtD
Imatinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.66e-05	0.000187	CcSEcCtD
Imatinib—Nausea—Hydrocortisone—systemic lupus erythematosus	3.64e-05	0.000186	CcSEcCtD
Imatinib—Rash—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000185	CcSEcCtD
Imatinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000185	CcSEcCtD
Imatinib—Anorexia—Methotrexate—systemic lupus erythematosus	3.64e-05	0.000185	CcSEcCtD
Imatinib—Rash—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000185	CcSEcCtD
Imatinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000185	CcSEcCtD
Imatinib—Urticaria—Prednisone—systemic lupus erythematosus	3.63e-05	0.000185	CcSEcCtD
Imatinib—Headache—Triamcinolone—systemic lupus erythematosus	3.62e-05	0.000184	CcSEcCtD
Imatinib—Headache—Methylprednisolone—systemic lupus erythematosus	3.61e-05	0.000184	CcSEcCtD
Imatinib—Abdominal pain—Prednisone—systemic lupus erythematosus	3.61e-05	0.000184	CcSEcCtD
Imatinib—Body temperature increased—Prednisone—systemic lupus erythematosus	3.61e-05	0.000184	CcSEcCtD
Imatinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.59e-05	0.000183	CcSEcCtD
Imatinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.59e-05	0.000183	CcSEcCtD
Imatinib—Hypotension—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000182	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000177	CcSEcCtD
Imatinib—Dizziness—Dexamethasone—systemic lupus erythematosus	3.47e-05	0.000177	CcSEcCtD
Imatinib—Dizziness—Betamethasone—systemic lupus erythematosus	3.47e-05	0.000177	CcSEcCtD
Imatinib—Insomnia—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000176	CcSEcCtD
Imatinib—Nausea—Triamcinolone—systemic lupus erythematosus	3.43e-05	0.000175	CcSEcCtD
Imatinib—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000174	CcSEcCtD
Imatinib—Nausea—Methylprednisolone—systemic lupus erythematosus	3.42e-05	0.000174	CcSEcCtD
Imatinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.4e-05	0.000173	CcSEcCtD
Imatinib—Somnolence—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000173	CcSEcCtD
Imatinib—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.36e-05	0.000171	CcSEcCtD
Imatinib—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000171	CcSEcCtD
Imatinib—Vomiting—Dexamethasone—systemic lupus erythematosus	3.33e-05	0.00017	CcSEcCtD
Imatinib—Vomiting—Betamethasone—systemic lupus erythematosus	3.33e-05	0.00017	CcSEcCtD
Imatinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000169	CcSEcCtD
Imatinib—Rash—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000168	CcSEcCtD
Imatinib—Rash—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000168	CcSEcCtD
Imatinib—Dermatitis—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000168	CcSEcCtD
Imatinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000168	CcSEcCtD
Imatinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.29e-05	0.000168	CcSEcCtD
Imatinib—Fatigue—Methotrexate—systemic lupus erythematosus	3.29e-05	0.000168	CcSEcCtD
Imatinib—Headache—Dexamethasone—systemic lupus erythematosus	3.28e-05	0.000167	CcSEcCtD
Imatinib—Headache—Betamethasone—systemic lupus erythematosus	3.28e-05	0.000167	CcSEcCtD
Imatinib—Asthenia—Prednisone—systemic lupus erythematosus	3.28e-05	0.000167	CcSEcCtD
Imatinib—Pain—Methotrexate—systemic lupus erythematosus	3.26e-05	0.000166	CcSEcCtD
Imatinib—Pruritus—Prednisone—systemic lupus erythematosus	3.23e-05	0.000164	CcSEcCtD
Imatinib—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.14e-05	0.00016	CcSEcCtD
Imatinib—Diarrhoea—Prednisone—systemic lupus erythematosus	3.12e-05	0.000159	CcSEcCtD
Imatinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.12e-05	0.000159	CcSEcCtD
Imatinib—Nausea—Dexamethasone—systemic lupus erythematosus	3.11e-05	0.000159	CcSEcCtD
Imatinib—Nausea—Betamethasone—systemic lupus erythematosus	3.11e-05	0.000159	CcSEcCtD
Imatinib—Urticaria—Methotrexate—systemic lupus erythematosus	3.03e-05	0.000154	CcSEcCtD
Imatinib—Dizziness—Prednisone—systemic lupus erythematosus	3.02e-05	0.000154	CcSEcCtD
Imatinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.02e-05	0.000154	CcSEcCtD
Imatinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.02e-05	0.000154	CcSEcCtD
Imatinib—Vomiting—Prednisone—systemic lupus erythematosus	2.9e-05	0.000148	CcSEcCtD
Imatinib—Rash—Prednisone—systemic lupus erythematosus	2.88e-05	0.000147	CcSEcCtD
Imatinib—Dermatitis—Prednisone—systemic lupus erythematosus	2.88e-05	0.000146	CcSEcCtD
Imatinib—Headache—Prednisone—systemic lupus erythematosus	2.86e-05	0.000146	CcSEcCtD
Imatinib—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000143	CcSEcCtD
Imatinib—Asthenia—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000139	CcSEcCtD
Imatinib—Nausea—Prednisone—systemic lupus erythematosus	2.71e-05	0.000138	CcSEcCtD
Imatinib—Pruritus—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000137	CcSEcCtD
Imatinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.61e-05	0.000133	CcSEcCtD
Imatinib—Dizziness—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000128	CcSEcCtD
Imatinib—Vomiting—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000124	CcSEcCtD
Imatinib—Rash—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000122	CcSEcCtD
Imatinib—Dermatitis—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000122	CcSEcCtD
Imatinib—Headache—Methotrexate—systemic lupus erythematosus	2.39e-05	0.000122	CcSEcCtD
Imatinib—Nausea—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000115	CcSEcCtD
Imatinib—LCK—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6e-06	5.08e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NOS3—systemic lupus erythematosus	6e-06	5.07e-05	CbGpPWpGaD
Imatinib—CA1—Metabolism—EP300—systemic lupus erythematosus	5.96e-06	5.04e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—C3—systemic lupus erythematosus	5.96e-06	5.04e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS3—systemic lupus erythematosus	5.94e-06	5.02e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—systemic lupus erythematosus	5.93e-06	5.01e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—RXRA—systemic lupus erythematosus	5.92e-06	5e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TYK2—systemic lupus erythematosus	5.9e-06	4.99e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—CDKN1B—systemic lupus erythematosus	5.89e-06	4.98e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TGFB1—systemic lupus erythematosus	5.86e-06	4.96e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	5.83e-06	4.93e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PRL—systemic lupus erythematosus	5.82e-06	4.92e-05	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—systemic lupus erythematosus	5.81e-06	4.92e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—JAK1—systemic lupus erythematosus	5.8e-06	4.91e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—systemic lupus erythematosus	5.78e-06	4.89e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	5.78e-06	4.89e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL2—systemic lupus erythematosus	5.76e-06	4.87e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—TYK2—systemic lupus erythematosus	5.75e-06	4.86e-05	CbGpPWpGaD
Imatinib—KIT—Disease—PTGS2—systemic lupus erythematosus	5.74e-06	4.85e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.72e-06	4.83e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CD80—systemic lupus erythematosus	5.61e-06	4.75e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.61e-06	4.74e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CDKN1B—systemic lupus erythematosus	5.57e-06	4.71e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—F2—systemic lupus erythematosus	5.53e-06	4.68e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IFNG—systemic lupus erythematosus	5.53e-06	4.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—systemic lupus erythematosus	5.5e-06	4.65e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCR5—systemic lupus erythematosus	5.5e-06	4.65e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—systemic lupus erythematosus	5.47e-06	4.63e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—systemic lupus erythematosus	5.47e-06	4.63e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL2—systemic lupus erythematosus	5.45e-06	4.61e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TYK2—systemic lupus erythematosus	5.45e-06	4.61e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CDKN1B—systemic lupus erythematosus	5.43e-06	4.6e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—CDKN1A—systemic lupus erythematosus	5.43e-06	4.59e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—systemic lupus erythematosus	5.43e-06	4.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.42e-06	4.58e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—systemic lupus erythematosus	5.39e-06	4.56e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—C3—systemic lupus erythematosus	5.37e-06	4.54e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS3—systemic lupus erythematosus	5.35e-06	4.52e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—systemic lupus erythematosus	5.34e-06	4.51e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CD80—systemic lupus erythematosus	5.3e-06	4.48e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS3—systemic lupus erythematosus	5.3e-06	4.48e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—EP300—systemic lupus erythematosus	5.24e-06	4.43e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—F2—systemic lupus erythematosus	5.23e-06	4.43e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—systemic lupus erythematosus	5.2e-06	4.4e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.19e-06	4.39e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD80—systemic lupus erythematosus	5.18e-06	4.38e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—EP300—systemic lupus erythematosus	5.17e-06	4.37e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CDKN1B—systemic lupus erythematosus	5.14e-06	4.35e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CDKN1A—systemic lupus erythematosus	5.14e-06	4.35e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—systemic lupus erythematosus	5.08e-06	4.3e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.04e-06	4.26e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CDKN1B—systemic lupus erythematosus	5.02e-06	4.24e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CD80—systemic lupus erythematosus	5.02e-06	4.24e-05	CbGpPWpGaD
Imatinib—KIT—Disease—CDKN1A—systemic lupus erythematosus	5.02e-06	4.24e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—systemic lupus erythematosus	4.96e-06	4.19e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	4.94e-06	4.18e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—systemic lupus erythematosus	4.93e-06	4.17e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL2—systemic lupus erythematosus	4.93e-06	4.17e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—systemic lupus erythematosus	4.91e-06	4.15e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—systemic lupus erythematosus	4.89e-06	4.14e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EP300—systemic lupus erythematosus	4.89e-06	4.14e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CDKN1B—systemic lupus erythematosus	4.89e-06	4.14e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—systemic lupus erythematosus	4.83e-06	4.09e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.81e-06	4.07e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.79e-06	4.05e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—systemic lupus erythematosus	4.79e-06	4.05e-05	CbGpPWpGaD
Imatinib—KIT—Disease—EP300—systemic lupus erythematosus	4.77e-06	4.04e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CDKN1A—systemic lupus erythematosus	4.75e-06	4.01e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—TYK2—systemic lupus erythematosus	4.74e-06	4.01e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—F2—systemic lupus erythematosus	4.72e-06	3.99e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL2—systemic lupus erythematosus	4.67e-06	3.95e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—JAK1—systemic lupus erythematosus	4.66e-06	3.94e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CDKN1B—systemic lupus erythematosus	4.63e-06	3.92e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CDKN1A—systemic lupus erythematosus	4.63e-06	3.92e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	4.6e-06	3.89e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.59e-06	3.88e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EP300—systemic lupus erythematosus	4.56e-06	3.86e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.53e-06	3.83e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CD80—systemic lupus erythematosus	4.52e-06	3.82e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EP300—systemic lupus erythematosus	4.52e-06	3.82e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CDKN1A—systemic lupus erythematosus	4.51e-06	3.82e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—systemic lupus erythematosus	4.49e-06	3.8e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TYK2—systemic lupus erythematosus	4.48e-06	3.78e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—systemic lupus erythematosus	4.44e-06	3.75e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.41e-06	3.73e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCR5—systemic lupus erythematosus	4.41e-06	3.73e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EP300—systemic lupus erythematosus	4.41e-06	3.73e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NOS3—systemic lupus erythematosus	4.39e-06	3.71e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TYK2—systemic lupus erythematosus	4.37e-06	3.7e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.35e-06	3.68e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.32e-06	3.65e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—C3—systemic lupus erythematosus	4.31e-06	3.65e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—EP300—systemic lupus erythematosus	4.3e-06	3.63e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS3—systemic lupus erythematosus	4.29e-06	3.63e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—systemic lupus erythematosus	4.28e-06	3.62e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CDKN1A—systemic lupus erythematosus	4.28e-06	3.62e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TYK2—systemic lupus erythematosus	4.24e-06	3.58e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.2e-06	3.55e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL2—systemic lupus erythematosus	4.2e-06	3.55e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NOS3—systemic lupus erythematosus	4.16e-06	3.52e-05	CbGpPWpGaD
Imatinib—KIT—Disease—TGFB1—systemic lupus erythematosus	4.15e-06	3.51e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.13e-06	3.49e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EP300—systemic lupus erythematosus	4.07e-06	3.44e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	4.05e-06	3.42e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—EP300—systemic lupus erythematosus	4.03e-06	3.41e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CDKN1B—systemic lupus erythematosus	4.03e-06	3.41e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	4.01e-06	3.39e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARG—systemic lupus erythematosus	4.01e-06	3.39e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—systemic lupus erythematosus	3.98e-06	3.36e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.96e-06	3.35e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.96e-06	3.35e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—RXRA—systemic lupus erythematosus	3.96e-06	3.35e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—systemic lupus erythematosus	3.96e-06	3.34e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—systemic lupus erythematosus	3.94e-06	3.33e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—systemic lupus erythematosus	3.93e-06	3.32e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—systemic lupus erythematosus	3.93e-06	3.32e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.92e-06	3.32e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	3.89e-06	3.29e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	3.82e-06	3.23e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TYK2—systemic lupus erythematosus	3.82e-06	3.23e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.81e-06	3.22e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.81e-06	3.22e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—F2—systemic lupus erythematosus	3.78e-06	3.2e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOS3—systemic lupus erythematosus	3.75e-06	3.17e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARG—systemic lupus erythematosus	3.74e-06	3.16e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—systemic lupus erythematosus	3.72e-06	3.15e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CDKN1B—systemic lupus erythematosus	3.72e-06	3.14e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CDKN1A—systemic lupus erythematosus	3.72e-06	3.14e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.67e-06	3.1e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	3.64e-06	3.08e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CD80—systemic lupus erythematosus	3.63e-06	3.07e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.61e-06	3.06e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	3.61e-06	3.05e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—systemic lupus erythematosus	3.6e-06	3.05e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.6e-06	3.05e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	3.55e-06	3e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—systemic lupus erythematosus	3.54e-06	2.99e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—EP300—systemic lupus erythematosus	3.54e-06	2.99e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.53e-06	2.98e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—systemic lupus erythematosus	3.53e-06	2.98e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MMP9—systemic lupus erythematosus	3.52e-06	2.98e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.51e-06	2.97e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	3.51e-06	2.96e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—systemic lupus erythematosus	3.5e-06	2.96e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	3.48e-06	2.95e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.47e-06	2.93e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	3.45e-06	2.92e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NOS3—systemic lupus erythematosus	3.45e-06	2.91e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CDKN1A—systemic lupus erythematosus	3.43e-06	2.9e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—systemic lupus erythematosus	3.39e-06	2.86e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL2—systemic lupus erythematosus	3.37e-06	2.85e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—systemic lupus erythematosus	3.36e-06	2.84e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	3.35e-06	2.83e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EP300—systemic lupus erythematosus	3.34e-06	2.83e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MMP9—systemic lupus erythematosus	3.34e-06	2.82e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.32e-06	2.81e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.3e-06	2.79e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.27e-06	2.76e-05	CbGpPWpGaD
Imatinib—LCK—Disease—EP300—systemic lupus erythematosus	3.27e-06	2.76e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.25e-06	2.74e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	3.24e-06	2.74e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NOS3—systemic lupus erythematosus	3.21e-06	2.72e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—systemic lupus erythematosus	3.2e-06	2.71e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.19e-06	2.69e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—systemic lupus erythematosus	3.18e-06	2.69e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.17e-06	2.68e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EP300—systemic lupus erythematosus	3.16e-06	2.67e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	3.16e-06	2.67e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—systemic lupus erythematosus	3.15e-06	2.67e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—systemic lupus erythematosus	3.13e-06	2.64e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.09e-06	2.61e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TYK2—systemic lupus erythematosus	3.06e-06	2.59e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	3.06e-06	2.59e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOS3—systemic lupus erythematosus	3.01e-06	2.54e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP9—systemic lupus erythematosus	3.01e-06	2.54e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3e-06	2.54e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	3e-06	2.53e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3e-06	2.53e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—systemic lupus erythematosus	2.99e-06	2.53e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—systemic lupus erythematosus	2.96e-06	2.5e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—systemic lupus erythematosus	2.94e-06	2.48e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.9e-06	2.46e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	2.9e-06	2.45e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—systemic lupus erythematosus	2.89e-06	2.44e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EP300—systemic lupus erythematosus	2.85e-06	2.41e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—systemic lupus erythematosus	2.84e-06	2.4e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—systemic lupus erythematosus	2.81e-06	2.38e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.77e-06	2.34e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.75e-06	2.33e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.7e-06	2.28e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—systemic lupus erythematosus	2.67e-06	2.25e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.65e-06	2.24e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	2.63e-06	2.22e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—EP300—systemic lupus erythematosus	2.62e-06	2.22e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.61e-06	2.21e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.6e-06	2.2e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.57e-06	2.17e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—systemic lupus erythematosus	2.55e-06	2.16e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—EP300—systemic lupus erythematosus	2.55e-06	2.15e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—systemic lupus erythematosus	2.5e-06	2.11e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.5e-06	2.11e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.48e-06	2.09e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—EP300—systemic lupus erythematosus	2.44e-06	2.07e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—systemic lupus erythematosus	2.41e-06	2.04e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.4e-06	2.03e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—systemic lupus erythematosus	2.32e-06	1.96e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EP300—systemic lupus erythematosus	2.29e-06	1.93e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2.28e-06	1.93e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.24e-06	1.9e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.19e-06	1.85e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—systemic lupus erythematosus	2.19e-06	1.85e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.17e-06	1.83e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—systemic lupus erythematosus	2.15e-06	1.82e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—systemic lupus erythematosus	2.14e-06	1.81e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.14e-06	1.81e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—systemic lupus erythematosus	2.07e-06	1.75e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.06e-06	1.74e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.05e-06	1.73e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2.02e-06	1.71e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.99e-06	1.68e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.97e-06	1.66e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.97e-06	1.66e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	1.93e-06	1.63e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	1.9e-06	1.61e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.88e-06	1.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—systemic lupus erythematosus	1.87e-06	1.58e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.86e-06	1.57e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.84e-06	1.56e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.77e-06	1.5e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	1.76e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.76e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.75e-06	1.48e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.72e-06	1.46e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—EP300—systemic lupus erythematosus	1.63e-06	1.38e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.62e-06	1.37e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.61e-06	1.36e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.57e-06	1.33e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.5e-06	1.27e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—systemic lupus erythematosus	1.5e-06	1.27e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.47e-06	1.24e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.43e-06	1.21e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.38e-06	1.16e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.35e-06	1.14e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.35e-06	1.14e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.34e-06	1.13e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.21e-06	1.03e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.16e-06	9.81e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.14e-06	9.67e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.06e-06	8.97e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	8.83e-07	7.46e-06	CbGpPWpGaD
